Frequency of regulatory T cells and its relationship with survival rate in patients with hepatocellular carcinoma
Shuo Li
Abstract
Shuo Li
Abstract
This study aimed to evaluate the relationship between the amount of CD4+CD25+Foxp3+ regulatory T cells in the circulation of patients with hepatocellular carcinoma(HCC) and the survival rate.We employed flow cytometry to analyze the relative proportions of CD4+CD25+Foxp3+ regulatory T cells in liver tissues and peripheral blood of 20 HCC patients and of healthy volunteers.After 3 years of follow-up,we retrospectively analyzed the patients.We found that the percentage of CD4+CD25+Foxp3+ regulatory T cells around the tumor tissues was 3.24%±1.42%,and the percentage of CD4+CD25+Foxp3+ regulatory T cells in the peripheral blood of HCC patients was 3.19%±1.56%,both of them were higher than those of the healthy volunteers 2.05%±1.20%(P 0.05).Furthermore,the frequency of CD4+CD25+Foxp3+ regulatory T cells is positively correlated the pathological stages of HCC,but negatively correlated with the survival of HCC.We concluded that CD4+CD25+Foxp3+ regulatory T cells may attenuate the anti-tumor immune responses of HCC patients.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This study aimed to evaluate the relationship between the amount of CD4+CD25+Foxp3+ regulatory T cells in the circulation of patients with hepatocellular carcinoma(HCC) and the survival rate.We employed flow cytometry to analyze the relative proportions of CD4+CD25+Foxp3+ regulatory T cells in liver tissues and peripheral blood of 20 HCC patients and of healthy volunteers.After 3 years of follow-up,we retrospectively analyzed the patients.We found that the percentage of CD4+CD25+Foxp3+ regulatory T cells around the tumor tissues was 3.24%±1.42%,and the percentage of CD4+CD25+Foxp3+ regulatory T cells in the peripheral blood of HCC patients was 3.19%±1.56%,both of them were higher than those of the healthy volunteers 2.05%±1.20%(P 0.05).Furthermore,the frequency of CD4+CD25+Foxp3+ regulatory T cells is positively correlated the pathological stages of HCC,but negatively correlated with the survival of HCC.We concluded that CD4+CD25+Foxp3+ regulatory T cells may attenuate the anti-tumor immune responses of HCC patients.
Key concepts: FOXP3, IL-2 receptor, Hepatocellular carcinoma, Flow cytometry, Regulatory T cell, Medicine, Pathological, Immune system